Science
Marinus Pharmaceuticals Announces Topline Results From TrustTSC Trial and Strategic Alternatives Exploration On October 24, 2024, Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) released the topline results from its Phase 3 TrustTSC Trial of Or
26 Oct 22:02 · 1 article